Enjoy complimentary customisation on priority with our Enterprise License!
The global Interleukin inhibitors market size will grow by USD 13.14 billion during 2019-2023. This market report provides a detailed analysis of the market by product (interleukin-23 inhibitors, interleukin-17 inhibitors, interleukin-6 inhibitors, and other interleukin inhibitors) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on many market vendors, including Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Novartis AG, and Regeneron Pharmaceuticals Inc.
Key Insights on Interleukin Inhibitors Market - Global Forecast 2019-2023
Browse TOC and LoE with selected illustrations and example pages of interleukin inhibitors market
Unlike conventional therapies, interleukin inhibitors work directly in interleukin receptors, making them highly effective in treating autoimmune disease. There are several approved interleukin inhibitor molecules available in the market for treating autoimmune conditions such as psoriasis, rheumatoid arthritis, and Crohn’s disease. Further R&D is ongoing on interleukin inhibitor molecules, and clinical trials for late-stage molecules will positively influence market growth. Higher patient adherence to these drugs because of their higher affinity and specificity, compared with other conventional approved autoimmune therapeutics, will increase their sales.
Various campaigns are being conducted by organizations across the world to raise awareness about autoimmune conditions such as rheumatoid arthritis, asthma, psoriasis, and others and their available treatment. For instance, the Know Your Arthritis Foundation in India has started a campaign to raise awareness about arthritis-related problems through radio programs, television interviews, and free medical camps. Asthma is another widely prevailing condition that requires attention, and campaigns are being organized to raise awareness about the indication. The success of these campaigns is increasing the sales of therapeutics, such as interleukin inhibitors. The interleukin inhibitors market analysis predicts that as a result of these factors, the market will register a CAGR of over 13% during 2019-2023.
The global market is fragmented. To help clients improve their market positions, this interleukin inhibitors market forecast report provides an analysis of the market’s competitive landscape and offers information on the drugs offered by various companies. The report also includes information on the upcoming interleukin inhibitors market trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
The report offers a detailed analysis of several leading interleukin inhibitors manufacturers, including:
The interleukin-23 inhibitors market segment held the largest market share in 2018. It will account for the highest interleukin inhibitors market share over the forecast period. The high prevalence of psoriasis improved R&D on interleukin-23 inhibitors and the development of a robust pipeline will boost the growth of the market segment during the forthcoming years. This report provides an accurate prediction of the contribution of all the segments to the growth of the interleukin inhibitors market size.
With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the interleukin inhibitors market throughout the forecast period. The recent approvals of various drugs, availability of patient assistance programs, and high prevalence of various autoimmune conditions are some of the factors that will contribute to interleukin inhibitors market growth in this region.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY PRODUCT
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
PART 11: MARKET TRENDS
PART 12: VENDOR LANDSCAPE
PART 13: VENDOR ANALYSIS
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.